A Leader in the canadian cannabis industry.

Since 2013, CannTrust has been delivering standardized products that enable physicians to provide accurate dosage to patients, similar to pharmaceuticals, all while rapidly building capacity and capability to expand into new categories: the adult use market, over-the-counter, natural healthcare products, pet care, and beauty.

For Investors

NYSE Ticker: CTST

TSE Ticker: TRST

Press release

CannTrust Provides Default Status Report

VAUGHAN, ON, Nov. 7, 2019 /CNW/ - CannTrust Holdings Inc. ("CannTrust" or the "Company",TSX: TRST, NYSE: CTST) today is providing a status update in accordance with its obligations under the alternative information guidelines set out in National Policy 12-203 –...

John Kaden Resigns from CannTrust’s Board of Directors

With Remediation Plan in Place, Company is Focused Upon Board Renewal VAUGHAN, ON, Oct. 28, 2019 /CNW/ – CannTrust Holdings Inc. ("CannTrust" or "the Company",TSX: TRST, NYSE: CTST) announced that, following both the recent submission of its detailed remediation plan...

CannTrust Provides Progress Update Regarding Remediation Plan

Special Committee investigation has concluded, Company continues to establish the foundation for a sustainable future VAUGHAN, ON - October 24, 2019 /CNW/ – CannTrust Holdings Inc. (“CannTrust” or “the Company”, TSX: TRST, NYSE: CTST) provided a progress update...

CannTrust Advances its Plan Towards Regulatory Compliance

Company to provide detailed remediation plan to Health Canada by October 21, 2019 VAUGHAN, ON, Oct. 14, 2019 /CNW/ – CannTrust Holdings Inc. ("CannTrust" or "the Company",TSX: TRST, NYSE: CTST) announced that it continues to make significant progress on its commitment...

CannTrust Provides Default Status Report

VAUGHAN, ON, Oct. 10, 2019 /CNW/ - CannTrust Holdings Inc. ("CannTrust" or the "Company",TSX: TRST, NYSE: CTST) today is providing a status update in accordance with its obligations under the alternative information guidelines set out in National Policy 12-203 –...

CannTrust Provides Default Status Report

VAUGHAN, ON, Sept. 26, 2019 /CNW/ - CannTrust Holdings Inc. ("CannTrust" or the "Company",TSX: TRST, NYSE: CTST) today is providing a status update in accordance with its obligations under the alternative information guidelines set out in National Policy 12-203 –...

CANNTRUST

Since 2013 CannTrust has been delivering standardized products that enable physicians to provide accurate dosage to patients, similar to pharmaceuticals, all while rapidly building capacity and capability to expand into new categories.

SUBSCRIBE TO INVESTOR NEWSLETTER

Subscribe Now

FOLLOW US

© CannTrust 2019

Terms & Conditions | Accessibility

Pin It on Pinterest